Covered stent carrying radioactive particles and manufacturing method thereof
By designing a coated scaffold for triangular prism radioactive particle inserts and baffles, combining bioreactor preparation and decellularization treatment, the problems of radioactive particles prone to falling off and inconvenient installation in the prior art are solved, and the stability of the scaffold is achieved and Treatment effect.
Patent Information
- Application Number
- CN202411006793.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-25
- Publication Date
- 2024-11-12
AI Technical Summary
Existing medical stents carrying radioactive particles are prone to fall off when the cavity duct is peristaltic, resulting in damage and bleeding. The radioactive particles are inconvenient to install and it is difficult to effectively treat tumors.
A coating bracket carrying radioactive particles was designed, using triangular prism-shaped radioactive particle inserts and baffles, fixed on the coating, using medical silicone material, and a radioactive particle loading hole was set between the radioactive particle inserts and baffles. and buffer holes, template preparation and decellularization treatment are used to form coating scaffolds to achieve stable fixation and installation of radioactive particles.
This stent can effectively prevent radioactive particles from falling off, reduce the risk of cavity damage, simplify radioactive particles installation, and realize the effect of conformal treatment and internal irradiation treatment of tumors.
Smart Images

Figure CN118924487A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of medical devices, and in particular to a coated stent carrying radioactive particles and a manufacturing method thereof. Background Art
[0002] Malignant tumors such as tracheal cancer, bile duct cancer, esophageal cancer and intestinal cancer generally originate in the cavity or are tumors that originate from other tissues and metastasize to the trachea, bile duct, and esophagus. When the tumor grows to a certain size, it will cause obstruction of the above-mentioned cavity and trigger corresponding clinical symptoms, which will eventually lead to malnutrition, decreased quality of life, and shortened survival of the patient.
[0003] At present, most patients with such diseases have difficulty and high risk in surgical removal of tumors, and they are mostly treated clinically by using medical stents to expand narrow cavities. Traditional medical stents rely on supporting force to open narrow cavities to restore the flow channels of these substances, thereby reducing or eliminating symptoms caused by obstruction. In addition, tumors or other lesions may compress surrounding tissues or organs, causing pain or other discomfort. After stents expand narrow cavities, this compression can be reduced, relieving pain and discomfort.
[0004] However, medical stents are mainly used to relieve symptoms and improve the patient's quality of life, rather than directly treat the tumor itself. The use of stents is a palliative treatment method that can help open narrow cavities, but it does not target the growth and spread of tumors. The problem of restenosis after surgery is indeed a clinical challenge.
[0005] In response to the above problems, medical stents carrying radioactive drugs have become an effective palliative treatment method in the current clinic. For example, patent CN201798827U discloses an intra-biliary irradiation stent, which places radioactive particles into a radioactive particle loading capsule fixed on the main frame, which not only expands the stenosis of the cavity but also inhibits tumor growth. Its disadvantage is that the radioactive particle loading capsule is tied to the main frame, and the position of the radioactive particle loading capsule is obviously protruding relative to the main frame. It is easy to fall off during normal physiological peristalsis in the cavity and easily cause internal damage and bleeding in the cavity, and the manufacturing process is complicated.
[0006] Patent CN215780962U discloses a covered stent carrying radioactive particles, which places the radioactive particles in the gap of the alloy tube of the braided stent, reducing the probability of radioactive particles falling off. However, in actual operation, the peristalsis of the cavity can easily cause the gap of the alloy tube to break due to stress concentration, and the radioactive particles fall off from the broken part, and the broken part can easily cause damage and bleeding inside the cavity.
[0007] In addition, the prior art CN113577525A discloses a conformable and adjustable internal radiation membrane stent for malignant tumors of human cavity organs, CN220477697U discloses a coated stent carrying radioactive particles, CN101695458A discloses a biliary radiotherapy stent, CN207462194U discloses a spiral particle stent, CN107569766A discloses a radioactive particle stent for intracavitary tumor radiotherapy, CN209236465U discloses a A stent carrying radioactive particles and tumor-suppressing factors, CN105188845A discloses a close-range treatment seed source insertion and fixation system, CN203001679U discloses an intraureteral irradiation stent, WO2024017329A1 discloses a stent implant and a preparation method thereof, US11690738B2 discloses a stent and a preparation method, EP4338714A1 discloses a drug-loaded stent. These prior arts have a common problem, that is, they are not convenient for the installation of radioactive particles. Summary of the invention
[0008] In order to solve the above problem, the present invention provides a coated stent carrying radioactive particles to solve the problem.
[0009] In order to achieve the above objectives, this application provides the following technical solutions:
[0010] A coated stent carrying radioactive particles, comprising: a stent and a coating, characterized in that: it also includes: a plurality of radioactive particle plugs and a plurality of radioactive particle baffles compatible with the radioactive particle plugs, the radioactive particle plugs and the radioactive particle baffles are respectively fixedly connected to the outer surface of the coating, and the end faces of the radioactive particle plugs adjacent to the radioactive particle baffles are provided with radioactive particle loading holes; the radioactive particle loading holes are blind holes.
[0011] It is further configured as follows: the radioactive particle plug and the radioactive particle baffle are both triangular prism structures, the quadrilateral surfaces of the radioactive particle plug and the radioactive particle baffle are the bottom surfaces and are configured as arc surfaces, the curvature of the two surfaces matches the curvature of the coating; a spacing of 0-1mm is configured between the radioactive particle plug and the radioactive particle baffle.
[0012] It is further configured that: the end faces adjacent to the radioactive particle baffle and the radioactive particle plug are provided with radioactive particle buffer holes, and the radioactive particle buffer holes are blind holes, and their length is shorter than the radioactive particle loading holes.
[0013] It is further configured that: the material of the plurality of radioactive particle plugs and the plurality of radioactive particle baffles is medical silica gel.
[0014] The present invention also provides a method for manufacturing a covered stent carrying radioactive particles, comprising the following steps:
[0015] S1: placing the scaffold preparation template in a bioreactor with cell culture fluid for flow culture;
[0016] S2: When the cells are fully grown, the scaffold is prepared into a template, the template is taken out, and demolding is performed to obtain a coated scaffold prototype;
[0017] S3: Decellularization and anticoagulation treatment are performed on the prototype of the coated stent to obtain the coated stent;
[0018] S4: shaping and drilling the radioactive particle plug to obtain a radioactive particle loading hole, and loading the radioactive particles into the radioactive particle loading hole;
[0019] S5: Fix the radioactive particle insert and the radioactive particle baffle carrying the radioactive particles in step S4 to the stent graft to obtain the stent graft carrying the radioactive particles.
[0020] Furthermore, the bracket preparation template includes an inner core, a fiber skeleton, an outer sleeve and a radioactive particle loading hole bracket, the fiber skeleton is arranged outside the inner core, the outer sleeve defines the fiber skeleton as a cylindrical cylinder with a plurality of openings, the outer sleeve is provided with openings penetrating the inner and outer walls of the outer sleeve, the radioactive particle loading hole bracket is arranged in the opening, and the radioactive particle loading hole bracket is fixed to the outside of the inner core.
[0021] Furthermore, the radioactive particle insert and the radioactive particle baffle can be manufactured as blanks using separate modules;
[0022] The mold set includes a first parting mold and a second parting mold. The first parting mold is set to a cylindrical shape, and a plurality of uniformly arrayed long grooves are opened on the upper surface of the first parting mold. The long grooves are in the shape of triangular prisms, and their inner side surfaces are arc surfaces consistent with the curvature of the coating. The second parting mold is set to a cylindrical shape, and a mold hole compatible with the first parting mold is opened on the upper surface of the second parting mold; the blanks of the radioactive particle plug and the radioactive particle baffle are formed in the axial cavity of the long grooves.
[0023] It is further configured as follows: a degradation layer is provided between the inner core and the fiber skeleton; and a degradation layer is provided between the outer shell and the fiber skeleton.
[0024] It is further configured as follows: the degradation layer is a coating, the coating material is a mixture of one or more of gelatin, collagen, hyaluronic acid, chitosan, PDO, PEO, and PGS in any proportion, and the coating thickness is 50-400 μm; the coating material is a mixture of gelatin and polydioxane barrels, and the weight or volume mixing ratio is 1:1 to 1:2.
[0025] It is further configured as follows: the fiber diameter of the fiber skeleton is 5-200 μm, the cross angle between the fibers of the fiber skeleton is 30-150°, the thickness of the fiber skeleton is 50-2000 μm, the standard deviation of the parallel spacing of the fibers of the fiber skeleton is between 5-10 μm, the standard deviation of the pore size of the fiber skeleton is within 5-30 μm; and the fiber skeleton is at least one layer;
[0026] Furthermore, the radioactive particle loading hole bracket is configured in a cross shape, a T shape or a straight shape.
[0027] Compared with the prior art, the beneficial technical effects of the present invention are:
[0028] 1. The coated stent carrying radioactive particles of the present invention places the radioactive particles into a radioactive particle insert fixed on the stent coating, which can not only dilate stenosis and drain, but also perform internal irradiation to treat tumors.
[0029] 2. The triangular prism structure of the radioactive particle insert and the radioactive particle baffle is large at the bottom and small at the top, which is easy to fix and adhere to the surface of the coating and form a whole with the stent. It is made of medical silicone material with good biocompatibility and elasticity, and is not easy to fall off due to cavity peristalsis and friction.
[0030] 3. The present invention can arrange the radioactive particle inserts at any position of the stent according to the specific requirements of the clinician to achieve conformal treatment of the tumor.
[0031] 4. The present invention has a simple structure and is easy to install radioactive particles, which reduces the risk of damage to the patient's cavity after implantation and reduces the patient's pain. BRIEF DESCRIPTION OF THE DRAWINGS
[0032] In order to more clearly illustrate the specific implementation methods of the present invention or the technical solutions in the prior art, the drawings required for use in the specific implementation methods or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are some implementation methods of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.
[0033] Figure 1 It is a schematic diagram of the overall structure of the stent graft of the present invention;
[0034] Figure 2 for Figure 1 A front view of
[0035] Figure 3 It is a schematic diagram of the structure of the radioactive particle plug and the radioactive particle baffle of the present invention;
[0036] Figure 4It is an enlarged schematic diagram of the longitudinal section of the stent graft of the present invention along the axial direction;
[0037] Figure 5 A schematic diagram of preparing a template for the scaffold of the present invention;
[0038] Figure 6 It is a structural schematic diagram of the first parting mold of the present invention;
[0039] Figure 7 It is a structural schematic diagram of the second mold division of the present invention.
[0040] Figure numerals: 1. bracket; 2. coating; 3. radioactive particle plug; 4. radioactive particle baffle; 5. radioactive particle loading hole; 6. radioactive particle buffer hole; 7. bracket preparation template; 8. inner core; 9. fiber skeleton; 10. outer cover; 101. radioactive particle loading hole bracket; 11. opening; 12. first parting mold; 13. second parting mold; 14. long groove; 15. mold hole. DETAILED DESCRIPTION
[0041] The technical solution of the present invention will be described clearly and completely below in conjunction with the accompanying drawings. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0042] In the description of the present invention, it should be noted that the terms "center", "upper", "lower", "left", "right", "vertical", "horizontal", "inner", "outer", etc., indicating the orientation or positional relationship, are based on the orientation or positional relationship shown in the drawings, and are only for the convenience of describing the present invention and simplifying the description, rather than indicating or implying that the device or element referred to must have a specific orientation, be constructed and operated in a specific orientation, and therefore cannot be understood as limiting the present invention. In addition, the terms "first", "second", and "third" are used for descriptive purposes only, and cannot be understood as indicating or implying relative importance.
[0043] In the description of the present invention, it should be noted that, unless otherwise clearly specified and limited, the terms "installed", "connected", and "connected" should be understood in a broad sense, for example, it can be a fixed connection, a detachable connection, or an integral connection; it can be a mechanical connection or an electrical connection; it can be a direct connection, or it can be indirectly connected through an intermediate medium, or it can be the internal communication of two components. For ordinary technicians in this field, the specific meanings of the above terms in the present invention can be understood according to specific circumstances.
[0044] Example 1
[0045] Reference Figure 1-Figure 4, is a coated stent carrying radioactive particles disclosed in the present invention, including a stent 1 and a coating 2, and also including a plurality of radioactive particle plugs 3 and a plurality of radioactive particle baffles 4. The radioactive particle plugs 3 and the radioactive particle baffles 4 are respectively fixedly connected to the outer surface of the coating 2, and both are triangular prism structures, with a spacing of 0-1mm between the two.
[0046] The quadrilateral surface of the radioactive particle plug 3 is the bottom surface and is arranged as an arc surface, and its curvature matches the curvature of the coating 2. The triangular surface of the radioactive particle plug 3 adjacent to the radioactive particle baffle 4 is provided with a radioactive particle loading hole 5. The radioactive particle loading hole 5 is a blind hole, and its cross section is circular, semicircular or polygonal, and more than one radioactive particle can be loaded at the same time.
[0047] A quadrilateral surface of the radioactive particle baffle 4 is the bottom surface and is set to an arc surface, and its curvature matches the curvature of the coating 2. The radioactive particle baffle 4 is solid or the triangular surface adjacent to the radioactive particle plug 3 is provided with a radioactive particle buffer hole 6. The radioactive particle buffer hole 6 is a blind hole, and its length is smaller than the radioactive particle loading hole 5.
[0048] The radioactive particle insert 3 and the radioactive particle baffle 4 are set to be a triangular prism with a large bottom and a small top, which is easy to be fixed and attached to the surface of the coating 2 and form a whole with the coating support;
[0049] Furthermore, the radioactive particle insert 3 and the radioactive particle baffle 4 are made of medical silicone material, which has good biocompatibility and elasticity and is not easily dropped due to cavity creeping friction.
[0050] The plurality of radioactive particle inserts 3 and the plurality of adjacent radioactive particle baffles 4 are equally spaced, rhombus-distributed or asymmetrically randomly distributed along the axial circumference of the stent 1. Specifically, the radioactive particle inserts 3 can be arranged at any position of the stent 1 according to the specific requirements of the clinician to achieve conformal treatment of the tumor.
[0051] Example 2
[0052] refer to Figure 1-5 This embodiment relates to a method for manufacturing a stent graft carrying radioactive particles, comprising the following steps:
[0053] The present invention also provides a method for manufacturing a covered stent carrying radioactive particles, comprising the following steps:
[0054] S1: placing the scaffold preparation template 7 in a bioreactor with a cell culture medium for flow culture;
[0055] S2: When the cells are fully grown, the scaffold preparation template 7 is taken out and demoulded to obtain a coated scaffold prototype;
[0056] S3: Decellularization and anticoagulation treatment are performed on the prototype of the coated stent to obtain the coated stent;
[0057] S4: shaping and drilling the radioactive particle insert 3 to obtain a radioactive particle loading hole 5, and loading the radioactive particles into the radioactive particle loading hole 5;
[0058] S5: Fix the radioactive particle insert 3 and the radioactive particle baffle 4 carrying the radioactive particles in step S4 to the stent graft to obtain the stent graft carrying the radioactive particles.
[0059] Example 3
[0060] Reference Figure 5 Similar to Example 2, this embodiment also relates to a method for manufacturing a covered stent carrying radioactive particles, comprising the following steps:
[0061] S1: placing the scaffold preparation template 7 in a bioreactor with a cell culture medium for flow culture;
[0062] S2: When the cells are fully grown, the scaffold preparation template 7 is taken out and demoulded to obtain a coated scaffold prototype;
[0063] S3: Decellularization and anticoagulation treatment are performed on the prototype of the coated stent to obtain the coated stent;
[0064] Different from Example 2, in the preparation method of this embodiment, the bracket preparation template 7 includes an inner core 8, a fiber skeleton 9, an outer sleeve 10 and a radioactive particle loading hole bracket 101, the fiber skeleton 9 is arranged outside the inner core 8, the outer sleeve 10 defines the fiber skeleton 9 as a cylindrical cylinder with a plurality of openings, the outer sleeve 10 is provided with an opening 11 that passes through the inner and outer walls of the outer sleeve 10, the radioactive particle loading hole bracket 101 is arranged in the opening 11, and the radioactive particle loading hole bracket 101 is fixed to the outside of the inner core 8.
[0065] Among them, after the prototype of the coated stent is decellularized and anticoagulated, the inner core 8 is removed, and then a composite layer with a fiber skeleton 9 and a cell-free matrix attached can be obtained; the opening 11 is also attached with a cell-free matrix layer, and then the radioactive particle loading hole bracket 101 is removed, so that the coated stent is formed as a whole. At this time, in this embodiment, there is no need to process the radioactive particle plug 3 and the radioactive particle baffle 4 separately, that is, the coating 2 and the radioactive particle plug 3 and the radioactive particle baffle 4 can be integrally formed at one time, and then the shape can be modified, and the inner layer of the coated stent with the inner core removed is a dense cell-free matrix layer, which can be used for body fluid to flow through. It can be understood by those skilled in the art that the outer coat 10 can be removed at this time, or the outer coat 10 can be retained. Because the outer coat 10 will also be attached with a cell-free matrix layer. It can also be understood by those skilled in the art that the technical terms "remove" or "remove" include removal by dissolving or precipitating with a chemical solvent. It will not be repeated here.
[0066] It is further configured as follows: a degradation layer is provided between the inner core and the fiber skeleton; and a degradation layer is provided between the outer shell and the fiber skeleton.
[0067] It is further configured as follows: the degradation layer is a coating, the coating material is a mixture of one or more of gelatin, collagen, hyaluronic acid, chitosan, PDO, PEO, and PGS in any proportion, and the coating thickness is 50-400 μm; the coating material is a mixture of gelatin and polydioxane barrels, and the weight or volume mixing ratio is 1:1 to 1:2.
[0068] It is further configured as follows: the fiber diameter of the fiber skeleton is 5-200μm, the crossing angle between the fibers of the fiber skeleton is 30-150°, the thickness of the fiber skeleton is 50-2000μm, the standard deviation of the parallel spacing of the fibers of the fiber skeleton is between 5-10μm, the standard deviation of the pore size of the fiber skeleton is within 5-30μm; and the fiber skeleton is at least one layer.
[0069] Furthermore, the radioactive particle loading hole bracket 101 is configured to be a cross, a T or a straight line.
[0070] The greatest advantage of this embodiment is that, since the cell culture medium is flow cultured in a bioreactor, the biocompatibility of the stent graft is very good. In addition, since the stent graft is integrally formed, only shaping or drilling is required after forming, which reduces the difficulty of installation.
[0071] Example 4
[0072] Different from the above-mentioned embodiments 2-3, in this embodiment, separate modules can be used to manufacture the coating and the radioactive particle insert 3 and the radioactive particle baffle 4 respectively. Figure 6-7.
[0073] First, the coated stent is manufactured in the manner of Example 3, but different from Example 3, the stent preparation template 7 in this embodiment only includes an inner core 8, a fiber skeleton 9, and an outer sleeve 10, and does not include a radioactive particle loading hole bracket 101. The radioactive particle plug 3 and the radioactive particle baffle 4 are manufactured using a separate module, and the module includes a first parting mold 12 and a second parting mold 13. The first parting mold 12 is configured to be cylindrical, and a plurality of uniformly arrayed long grooves 14 are provided on the upper surface of the first parting mold 12. The long grooves 14 are in the shape of a triangular prism, and the inner side surface thereof is an arc surface consistent with the curvature of the coating 2. The second parting mold 13 is configured to be cylindrical, and a mold hole 15 compatible with the first parting mold 12 is provided on the upper surface of the second parting mold 13; the blanks of the radioactive particle plug and the radioactive particle baffle 4 are formed in the axial cavity of the long groove 14.
[0074] In order to improve production efficiency, the blanks of the radioactive particle plug and the radioactive particle baffle 4 can be formed at one time by a module, and then subsequently divided, shaped and drilled; the radioactive particle plug 3 is drilled to obtain a radioactive particle loading hole 5, and the radioactive particles are loaded into the radioactive particle loading hole 5; the radioactive particle plug 3 carrying the radioactive particles and the radioactive particle baffle 4 are fixed to the coated stent to obtain a coated stent carrying the radioactive particles.
[0075] Furthermore, in step S5 , the radioactive particle baffle 4 may be drilled to obtain the radioactive particle buffer holes 6 .
[0076] Furthermore, a degradation layer is provided between the inner core 8 and the fiber skeleton 9; a degradation layer is provided between the outer shell 10 and the fiber skeleton 9; the degradation layer is a coating, and the coating material is a mixture of one or more of gelatin, collagen, hyaluronic acid, chitosan, PDO, PEO, and PGS in any proportion, and the coating thickness is 50-400 μm; the coating material is a mixture of gelatin and polydioxane (PDO), and the weight or volume mixing ratio is 1:1 to 1:2.
[0077] Furthermore, the cross section of the inner core 8 is cylindrical, the outer shape of the inner core 8 is cylindrical, and the fiber skeleton 9 and the outer jacket 10 are adapted to the shape of the inner core 8 .
[0078] Furthermore, the fiber diameter of the fiber skeleton 9 is 5-200μm, the crossing angle between the fibers of the fiber skeleton 9 is 30-150°, the thickness of the fiber skeleton 9 is 50-2000μm, the standard deviation of the parallel spacing of the fibers of the fiber skeleton 9 is between 5-10μm, and the standard deviation of the pore size of the fiber skeleton 9 is within 5-30μm; and the fiber skeleton 9 is one layer or n layers, wherein n≥2; when the fiber skeleton 9 is n layers, the layers of the fiber skeleton 9 are integrally formed or separately formed and then sleeved or connected together; the layers of the fiber skeleton 9 are in direct contact with each other or are provided with a degradation layer.
[0079] Further, the openings 11 on the outer sleeve 10 are a plurality of grooves or a plurality of holes, or a combination of a plurality of grooves and a plurality of holes;
[0080] Specifically, when the opening 11 is a groove, the shape of the groove is a continuous straight groove or a plurality of spaced straight grooves opened along the axial direction of the outer sleeve 10, the angle between the straight groove and the axis of the axial direction of the outer sleeve 10 is 0-90°, the widths of the plurality of straight grooves are equal or unequal, and the shape of the projection of the straight groove in the corresponding groove direction is a rectangle, a racetrack or a trapezoid;
[0081] When the opening 11 is a hole, the shape of the hole is a circle or an m-gon, m≥3, and the shapes of the holes are the same or different.
[0082] Furthermore, the material of the inner core 8 is one of medical silicone, stainless steel, nylon or polyurethane, and the preparation material of the fiber skeleton 9 is one or a mixture of any proportion of poly (lactide-glycolic acid), copolymer (PLGA), polyglycolic acid (PGA), polylactide (PLA), polyhydroxyalkanoate (PHA), polydioxanone (PDS), polycaprolactone (PCL), poly (lactide-caprolactone) copolymer (PLCL), polyurethane (PU), polysebacic acid glycerol (PGS), or polyethylene glycol (PEO).
[0083] Furthermore, the fiber skeleton 9 is prepared by one of electrospinning, melt spinning, 3D printing, and fiber weaving.
[0084] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit it. Although the present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that they can still modify the technical solutions described in the aforementioned embodiments, or replace some or all of the technical features therein by equivalents. However, these modifications or replacements do not cause the essence of the corresponding technical solutions to deviate from the scope of the technical solutions of the embodiments of the present invention.
Claims
1. A covered stent carrying radioactive particles, characterized in that: include: The support (1) and the coating (2) are characterized in that they also include: a plurality of radioactive particle plugs (3) and a plurality of radioactive particle baffles (4) matched with the radioactive particle plugs (3), wherein the radioactive particle plugs (3) and the radioactive particle baffles (4) are respectively fixedly connected to the outer surface of the coating (2), and the end faces of the radioactive particle plugs (3) and the radioactive particle baffles (4) adjacent to each other are provided with radioactive particle loading holes (5); the radioactive particle loading holes (5) are blind holes.
2. The stent graft carrying radioactive particles according to claim 1, characterized in that: The radioactive particle insert (3) and the radioactive particle baffle (4) are both triangular prism structures; the quadrilateral surfaces of the radioactive particle insert (3) and the radioactive particle baffle (4) are bottom surfaces and are arranged as arc-shaped surfaces; the curvatures of the two surfaces match the curvature of the coating (2); and a spacing of 0-1 mm is arranged between the radioactive particle insert (3) and the radioactive particle baffle (4).
3. The stent graft carrying radioactive particles according to claim 2, characterized in that: The end surfaces adjacent to the radioactive particle baffle (4) and the radioactive particle insert (3) are provided with radioactive particle buffer holes (6), and the radioactive particle buffer holes (6) are blind holes, and their length is shorter than the radioactive particle loading holes (5).
4. The stent graft carrying radioactive particles according to claim 1, characterized in that: The material of the plurality of radioactive particle inserts (3) and the plurality of radioactive particle baffles (4) is medical silica gel.
5. A method for manufacturing a covered stent carrying radioactive particles, applied to a covered stent carrying radioactive particles as claimed in any one of claims 1 to 4, characterized in that: The following steps are involved: S1: placing the scaffold preparation template (7) in a bioreactor with a cell culture medium for flow culture; S2: When the cells are fully grown, the scaffold is prepared into a template (7), the template is taken out and demoulded to obtain a prototype of the coated scaffold; S3: Decellularization and anticoagulation treatment are performed on the prototype of the coated stent to obtain the coated stent; S4: shaping and drilling the radioactive particle insert (3) to obtain a radioactive particle loading hole (5), and loading the radioactive particles into the radioactive particle loading hole (5); S5: Fix the radioactive particle insert (3) and the radioactive particle baffle (4) carrying the radioactive particles in step S4 to the stent graft to obtain the stent graft carrying the radioactive particles.
6. The method for manufacturing a covered stent carrying radioactive particles according to claim 5, characterized in that: The support preparation template (7) comprises an inner core (8), a fiber skeleton (9), an outer shell (10) and a radioactive particle loading hole support (101); the fiber skeleton (9) is arranged outside the inner core (8); the outer shell (10) defines the fiber skeleton (9) as a cylindrical cylinder with a plurality of openings; the outer shell (10) is provided with an opening (11) penetrating the inner and outer walls of the outer shell (10); the radioactive particle loading hole support (101) is arranged in the opening (11); and the radioactive particle loading hole support (101) is fixed outside the inner core (8).
7. The method for manufacturing a stent graft carrying radioactive particles according to claim 5, characterized in that: The radioactive particle loading hole support (101) is configured in a cross shape, a T shape or a straight shape.
8. The method for manufacturing a covered stent carrying radioactive particles according to claim 5, characterized in that: The radioactive particle insert (3) and the radioactive particle baffle (4) can be manufactured as blanks using separate mold sets; The mold assembly comprises a first parting mold (12) and a second parting mold (13); the first parting mold (12) is arranged in a cylindrical shape, and a plurality of uniformly arrayed long grooves (14) are provided on the upper surface of the first parting mold (12); the long grooves (14) are in the shape of triangular prisms, and the inner side surfaces thereof are arc surfaces consistent with the arc of the coating (2); the second parting mold (13) is arranged in a cylindrical shape, and a mold hole (15) adapted to the first parting mold (12) is provided on the upper surface of the second parting mold (13); the blanks of the radioactive particle insert and the radioactive particle baffle (4) are formed in the axial cavity of the long grooves (14).
9. The method for manufacturing a stent graft carrying radioactive particles according to claim 6, characterized in that: A degradation layer is provided between the inner core (8) and the fiber skeleton (9); and a degradation layer is provided between the outer shell (10) and the fiber skeleton (9).
Citation Information
Patent Citations
Biliary tract radiation treatment stent
CN101695458A
Brachytherapy seed insertion and fixation system
CN105188845A
Radioactive particle stent used for radiotherapy in cavity tumor
CN107569766A
Conformal and adjustable internal radiation membranous stent for malignant tumors of human body cavity visceral organs
CN113577525A
Biliary tract internal exposure support
CN201798827U
